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Abstract
Rationale: We had shown that COPD women expressed more dyspnea than men for the same
degree of airway obstruction.
Objectives: Evaluate gender differences in respiratory factors associated with dyspnea in COPD
patients.
Methods: In a FEV1 % matched population of 100 men and women with COPD we measured: age,
MMRC, FEV1, FVC, TLC, IC/TLC, PaO2, PaCO2, DLCO, Pimax, P0.1, Ti/Ttot, BMI, ffmi, 6MWD and
VAS scale before and after the test, the Charlson score and the SGRQ. We estimated the
association between these parameters and MMRC scores. Multivariate analysis determined the
independent strength of those associations.
Results: MMRC correlated with: BMI (men:-0.29, p = 0.04; women:-0.28, p = 0.05), ffmi (men:-
0.39, p = 0.01), FEV1 % (men:-0.64, p < 0.001; women:-0.29, p = 0.04), FVC % (men:-0.45, p = 0.001;
women:-0.33, p = 0.02), IC/TLC (men:-0.52, p < 0.001; women: -0.27, p = 0.05), PaO2 (men:-0.59,
p < 0.001), PaCO2 (men:0.27, p = 0.05), DLCO (men:-0.54, p < 0.001), P0.1/Pimax (men:0.46, p = 0.002;
women:0.47, p = 0.005), dyspnea measured with the Visual Analog Scale before (men:0.37, p = 0.04;
women:0.52, p = 0.004) and after 6MWD (men:0.52, p = 0.002; women:0.48, p = 0.004) and SGRQ
total (men:0.50, p < 0.001; women:0.59, p < 0.001). Regression analysis showed that P0.1/Pimax in
women (r2 = 0.30) and BMI, DLCO, PaO2 and P0.1/Pimax in men (r2 = 0.81) were the strongest
predictors of MMRC scores.
Conclusion: In mild to severe COPD patients attending a pulmonary clinic, P0.1/Pimax was the
unique predictor of MMRC scores only in women. Respiratory factors explain most of the
variations of MMRC scores in men but not in women. Factors other than the respiratory ones
should be included in the evaluation of dyspnea in women with COPD.
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The influence of gender on the expression of chronic
obstructive pulmonary disease (COPD) has received lim-
ited attention [1-3].
Dyspnea has been defined as the subjective experience of
breathing discomfort consisting in qualitatively distinct
sensations that vary in intensity and is derived from inter-
actions among multiples physiological, psychological,
social and environmental factors [4]. It is the most impor-
tant symptom of COPD patients and the main determi-
nant of their Quality of Life (QoL) [5].
In the United States, in the year 2000, more women died
from COPD than men [6]. We have recently shown in a
population of patients with COPD attending an outpa-
tient clinic, that for the same degree of airway obstruction,
women expressed more dyspnea than men at earlier stages
of the disease [7].
We therefore hypothesised that systematically studying
and comparing different respiratory factors known to con-
tribute to dyspnea in a population of men and women
with COPD could help us identify those factors associated
with the symptom. Knowledge of these factors, could aid
us in the development of tailored strategies aimed at
decreasing dyspnea in the female COPD population
where this important symptom presents at younger age
and earlier stages of the disease. To pursue our goal we
called back our patients within the next year of the previ-
ous study [7]. At this new appointment we repeated the
same original evaluation and also measured other impor-
tant respiratory factors like the central drive (P0.1), the
inspiratory and expiratory maximal pressures (Pimax,
Pemax), the inspiratory capacity to total lung capacity ratio
(IC/TLC) and the breathing pattern (respiratory rate and
Ti/Ttot).
Methods
This FEV1% case series study, recruited men and post-
menopausal women with COPD attending an outpatient
clinic at Hospital Universitario Ntra Sra de Candelaria; a
tertiary public university hospital in Spain from January
2000 to December 2005. Patients with all degree of air-
flow severity were included if they had smoked ≥ 20 pack
years and had a post-bronchodilator FEV1/FVC of <0.7
after 400 micrograms of inhaled albuterol. Patients were
excluded if they had a history of asthma, had a history of
bronchiectasis, tuberculosis or other confounding dis-
eases. We decided to include only those patients with air-
way obstruction, therefore patients with GOLD stage 0
were not included. The patients were clinically stable (no
exacerbation for at least 2 months) at the time of the eval-
uation and were part of the BODE international multi-
center study [8]. The Ethical Committee of the Hospital
approved the study and all patients signed the informed
consent.
We evaluated the following parameters in the study sam-
ple: age, BMI (weight in kilograms divided by height in
meters2), ffmi was determined using the bioelectrical
impedance Bodystat (Isle of Man, British Isles) and divid-
ing the free fat mass weight in kilograms by height in
meters2, pulmonary function tests (FEV1, FVC, TLC, IC/
TLC, FRC, DLCO), resting arterial blood gases (PaO2,
PaCO2), dyspnea by the Modified Medical Research
Council scale (MMRC) [9] and by the Visual Analog Scale
(VAS) [10] immediately before and after the 6-minute
walk distance (6MWD test) [11], maximal inspiratory
pressures (Pimax), breathing pattern (respiratory rate, Ti/
Ttot, mouth occlusion pressure (P0.1), and presence of
comorbidities by the Charlson scale [12].
Pulmonary Function Tests
Postbronchodilator FEV1 % of predicted, FVC % of pre-
dicted and FEV1/FVC, IC, TLC, FRC, DLCO values were
determined using the European Community for Steel and
Coal for Spain as reference values [13] and using a Jaegger
920 MasterLab® Body Box. Inspiratory Capacity was meas-
ured immediately before (the best of 3 manoeuvres) and
after the 6MWD as previously described [14]. From the
lung volume measurements we also determined their IC/
TLC ratio.
Pimax and breathing pattern measurements
Pimax was measured in sitting position after 15 minutes of
rest from FRC using the technique and predictive values of
Black and Hyatt [15]. Breathing pattern was measured
also in sitting position after 15 minutes of rest and having
carefully explained the manoeuvre to obtain and appro-
priate measurement. We measured respiratory rate, inspir-
atory time (Ti), expiratory time (Te) and total breathing
time (Ttot).
Respiratory drive measurements
The measurement of mouth occlusion pressure (P0.1) was
performed following the recommendations of Burki et al
[16]. To better reflect the central respiratory output of our
patients, we calculated the P0.1/Pimax index as we have pre-
viously reported [17].
Data processing
We describe each variable using mean ± SD or median
(25th percentile – 75th percentile) depending on their dis-
tribution. A multivariate regression analysis with MMRC
score as the dependent variable and those parameters that
shown to be different between men and female as predic-
tors of its changes was performed. We tested correlations
between the MMRC score and the study parameters by
non-parametric Spearman's rank or tau-b Kendall's linearPage 2 of 7
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MMRC scales. We then performed a multiple linear regres-
sion analysis with MMRC score as the dependent variable
and those factors and parameters that shown statistical
significant correlation with it (Men: BMI, FEV1%, IC/TLC,
DLCO, PaO2 and P0.1/Pimax; Women: BMI, FEV1%, IC/
TLC and P0.1/Pimax). A p value = 0.05 was considered sta-
tistical significant. The analysis was performed with the
statistical package SPSS® version 12, Chicago, IL, USA.
We describe the matching method as follows: we took our
matched patients from an initial sample of 116 males and
59 females with COPD; we were able to matched every
female patient with a male with FEV1 % of predicted ± 2%;
when more than one male matched, we randomly chosen
the patient to be included in the final sample, being blind
to the rest of the evaluated parameters.
Results
We were able to match 56 men and 56 women. Four men
and six women did not appropriately complete the tests or
dropped out of the study. The patients were white of Euro-
pean descent. When enrolled 48% of them were still
smoking. Using the GOLD staging system [18], there were
the same number of men and women at each stage, dis-
tributed as follows: stage I: 25%, stage II: 52%, stage III:
17% and stage IV: 3%.
Table 1 shows the comparison of clinical and physiologi-
cal characteristics of the population. Compared with men,
women were younger, smoked less, expressed more dysp-
nea as shown in figure 1, had the same BMI but lower
ffmi, a lower diffusion capacity, a higher respiratory center
output and walked less in the 6MWD. As expected for an
FEV1% matched population no differences were found in
the other respiratory parameters.
The multivariate regression analysis with MMRC score as
the dependent variable confirmed that only gender (B
coefficient: 0.4; 95% CI: 0.1 to 0.8; p = 0.04), age (0.02;
0.007 to 0.032; p = 0.004), p0.1 (1.79; 0.19 to 3.38; p =
0.03) and DLCO (-0.01; -0.02 to -0.007) explained its var-
iations.
Table 2 shows the correlation coefficients between MMRC
scores and the studied parameters that reached statistical
Table 1: Clinical and physiologic characteristics of men and women participating in the study.
Clinical & Physiological 
Characteristics
Men* n = 50 Women* n = 50 p value
Age (years old) 67 ± 8 56 ± 11 <0.001
Pack years history 69 ± 27 48 ± 28 <0.001
MMRC (points)
0 (%) 35 (70) 11 (22) <0.001
1–4 (%) 15 (30) 35 (78) <0.001
BMI (kg/m2) 27 ± 4 27 ± 6 ns
BMI≤21(%) 5 (10%) 8 (16%) ns
ffmi (kg/m2) 18 ± 3 15 ± 2 <0.001
Charlson Score (points) 2 (2–3) 2(1–4) ns
FEV1 % of predicted 63 ± 17 63 ± 17 ns
FVC % of predicted 91 ± 18 92 ± 21 ns
FEV1/FVC % of predicted 60 ± 12 60 ± 13 ns
FRC % of predicted 134 ± 38 134 ± 27 ns
TLC % of predicted 113 ± 21 114 ± 21 ns
IC/TLC (%) 36 ± 8 36 ± 7 ns
IC/TLC<0.25 (%) 6 (12) 4 (7) ns
Respiratory rate 18 ± 4 19 ± 4 ns
Ti/Ttot 0,40 ± 0,06 0.41 ± 0.06 ns
PaO2 (mmHg) 76 ± 12 76 ± 9 ns
PaCO2 (mmHg) 41 ± 4 40 ± 4 ns
DLCO (%) 87 ± 30 72 ± 20 0.02
Pimax % of predicted 67 ± 22 50 ± 20 <0.001
P0.1 0.27 ± 0.11 0.34 ± 0.19 <0.001
P0.1 % of predicted 117 ± 12 155 ± 35 <0.001
P0.1/Pimax 0.04 ± 0.02 0.06 ± 0.05 <0.001
6MWD (meters) 522 ± 90 461 ± 85 0.001
IC/TLC post 6MWD(Lt) 0.31 ± 0.09 0.31 ± 0.08 ns
VAS pre 6MWD (cm) 1 ± 1 3 ± 2 0.05
VAS post 6MWD (cm) 3 ± 2 5 ± 2 0.005
mean ± SD or median(25th–75th percentiles) depending on scale measurement and sample distribution; ns = statistically non significant.Page 3 of 7
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with: BMI, FEV1%, IC/TLC, DLCO, PaCO2 and PaO2, P0.1/
Pimax, VAS before and after the 6MWD and QoL and in
women: BMI, FEV1%, IC/TLC,, P0.1/Pimax, VAS before and
after the 6MWD and QoL. IC/TLC after the 6MWD corre-
lated with dyspnea after the test in men (-0.36, p = 0.04)
and women (-0.40, p = 0.03). No statistically significant
correlation was found between MMRC and age or pack
year history for women.
A multiple regression analysis with MMRC as dependent
variable and all factors that significantly correlated with it
that represent each domain are shown in Table 3. The P0.1/
Pimax in women and BMI, DLCO, PaO2 and P0.1/Pimax in
men had the strongest independent associations with
MMRC scores.
Discussion
To our knowledge this is the first study exclusively
designed to study differences in respiratory factors associ-
ated to dyspnea in a population sample of men and
women with COPD and equivalent degree of airway
obstruction. The most important findings are: 1. P0.1/Pimax
correlate with MMRC scores in both genders, but was the
unique predictor of its scores only in women. 2. Respira-
tory factors explain most of the variations in MMRC scores
in males but not in women with COPD.
Dyspnea is one of the leading symptoms and sometimes
the only one affecting patients suffering from COPD.
Functional dyspnea has been shown to be a strong predic-
tor of survival [8,19], and an important treatable symp-
tom of the disease [20]. The development of dyspnea in
patients with COPD is multifactorial and has been shown
to be related to the degree of airway obstruction, pulmo-
nary gas exchange abnormalities, nutritional status,
inspiratory muscle strength, lung hyperinflation, respira-
tory central output, psychological as well as socio-cultural
factors [4].
We [7] and others [21] have reported that compared with
men, women with COPD report more functional dyspnea
for the same degree of airway obstruction. In our initial
study we observed that dyspnea appears at earlier stages of
the disease in women than in men. In an attempt to find
explanations for that observation, we decide to explore
the possible association of several of the main respiratory
factors thought to be responsible for dyspnea in patients
with COPD. We chose patients with mild to severe COPD
because this is the group where dyspnea appears to
develop earlier in women [7].
Table 2: Correlation coefficients of factors that showed significant correlations with the functional dyspnea score as determined with 
the Modified Medical Research Council scale.




FEV1 % -0.64 -0.45






VAS pre 6MWD 0.37 0.52
VAS post 6MWD 0.52 0.48
Estimated by Spearman's rank or tau-b Kendall linear correlation coefficients; ns = stastistically non significant  
Distribution of MMRC score in COPD men and womenFigure 1
Distribution of MMRC score in COPD men and women. p < 
0.05 for the comparison between men and women MRC 
scores.Page 4 of 7
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ratory output is an important factor in the genesis of the
dyspnea sensation in patients with severe COPD [22].
Interestingly, in the present study we found that com-
pared with men, women with similar FEV1%, FVC%,
TLC%, PaO2, PaCO2 and IC/TLC ratio have a higher cen-
tral respiratory drive. In the multivariate analysis the P0.1/
Pimax was the only independent respiratory factor associ-
ated with MMRC scores in women. This is even more
important considering that all of our patients were post-
menopausal, normoxyemic, normocapnic, well nour-
ished and with a good exercise capacity at the early stages
of the disease. Knowing the important stimulant effect
that progesterone has on the respiratory center [23] the
post menopausal state makes our findings in these
patients even more important as lower levels of progester-
one tend to decrease the output of the respiratory drive.
The exact reason for this association remains unexplored.
However, post-menopausal women may manifest unique
changes in their physiological responses compared with
pre-menopausal women. Indeed, post-menopausal
women have less reactive pulmonary vasculature and
therefore may develop dyspnea at lower levels of physio-
logical stress compared with pre-menopausal women
[24]. New studies addressing these and other mechanisms
should provide important useful information.
In our study we also found that the degree of airway
obstruction measured by the FEV1 and FVC significantly
correlated with MMRC score as previously reported by
Bestall et al [25]. However, the association between the
degree of airway obstruction and degree dyspnea was not
strong enough to be retained in the regression analysis
models of both men and women. This could be partially
explained by the fact that our COPD group is composed
mainly of mild to moderate patients, and probably in
these stages airway obstruction does not play an impor-
tant role in the development of dyspnea.
Lung hyperinflation is one of the most important factors
related to the development of dyspnea in patients with
COPD. It is associated with exertional dyspnea [26] and
has also been shown to be an important independent pre-
dictor of survival [27]. We found that lung hyperinflation
measured by the IC/TLC ratio was associated with func-
tional dyspnea to a similar degree in both genders. We
also confirmed in our patients that the degree of air
trapped on exertion correlates with the degree dyspnea
developed, implying that lung hyperinflation plays an
important limiting factor in their activities of daily living.
The importance of arterial levels of O2 and CO2 in the
development of dyspnea in COPD patients is well known
[4]. Not surprisingly, their levels as well as the diffusion
capacity correlated well with MMRC scores in the male
COPD population. Indeed, O'Donnell et al [28] previ-
ously reported significant correlation between DLCO and
dyspnea rating in a population of severely dyspneic
COPD patients, even though that the exact physiopatho-
logical mechanism is not well described. Interestingly,
none of these parameters correlated with MMRC scores in
the female patients, implying that probably this is not the
most important reason why women with COPD have dys-
pnea.
Dyspnea has been also associated with the degree of mal-
nutrition specially affecting the respiratory muscles [29].
We confirmed this in our COPD population where we
observed an inverse relationship between BMI and MMRC
(r = -0.26) similar to that described by Sahebjami et al
[29]. This association was not strong enough to remain in
the regression model for women, probably implying that
malnutrition is not as important in women at these stages
of the disease, even considering that they have a lower
exercise capacity and Pimax than men with COPD.
We also observed that MMRC and VAS before 6MWD had
a strong correlation confirming the face validity of our
data and reproducing recent data from Oga et al in a sam-
ple of 143 men with COPD [30]. Furthermore, the VAS
after 6MWD also correlated with MMRC, implying that
the degree of dypnea developed after an exercise test is
similar to the one perceived in their activities of daily liv-
ing as measured by the MMRC, a finding that is similar to
that reported by Gallego et al [31].
Very important information is obtained when we analyse
the respiratory factors retained in the multivariate regres-
Table 3: Multiple linear regression with functional MMRC score as dependent variable and those parameters with significant 
correlation with it. Men included: BMI, FEV1%, IC/TLC, DLCO, PaO2 and P0.1/Pimax; Women included: BMI, FEV1%, IC/TLC and P0.1/
Pimax.
Parameter Regression Coefficient 95% CI p-Value
Men r2 = 0.81 BMI -0.70 -0.23 to -0.09 0.001
DLCO 0.32 0.001 to 0.02 0.037
PaO2 -0.78 -0.08 to -0.05 <0.001
P0.1/Pimax 0.20 0.16 to 21.6 0.047
Women r2 = 0.30 P0.1/Pimax 0.57 4.9 to 17.1 0.001Page 5 of 7
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various respiratory factors associated with dyspnea such as
nutritional status, carbon monoxide diffusion capacity,
level of oxygenation and central respiratory output are
responsible for 81% of the variation of MMRC scores in
men with COPD. In contrast, we found that the single best
predictor of MMRC scores in women, is the central respi-
ratory output but only explaining 30% of its variation.
This important finding indicates the need to evaluate
novel factors to explain the genesis of dyspnea in women
with mild to moderate COPD. Perhaps non respiratory
factors such as anxiety, depression or coping mechanisms
may play an important role in the perception of dyspnea
in women. We support our hypothesis considering that
anxiety and depression are highly prevalent in women
with COPD and has been shown to be tightly associated
with their degree of dyspnea [32] and knowing that men
and women with COPD have different coping mecha-
nisms [33]. Our findings also support the findings of Lap-
perre et al [34] who have suggested that COPD is a
heterogeneous disease in terms of its clinical and physio-
logical presentation.
Our study has several limitations. First, the findings here
presented should be restricted to a population with simi-
lar characteristics of ours, namely men and women with
mild to moderate COPD attending an outpatient clinic. It
would be interesting to know if these findings are repro-
ducible in populations of severe to very severe COPD
patients. We speculate that probably in this group, lung
hyperinflation may play a more important role. Second,
we did not evaluate anxiety or depression as possible fac-
tors associated with dyspnea, but the goal of the study was
to only explore the relationship of respiratory factors and
dyspnea.
In conclusion, the central respiratory output is associated
with functional dyspnea in both men and women with
mild to severe COPD who attend an outpatient clinic. The
central output was the single best predictor of MMRC
scores only in women. Respiratory factors explained most
of the variations of MMRC scores in men but not in
women. We propose that other factors should be system-
atically explored in the evaluation of causes of dyspnea in
women with COPD. Further studies in women of different
age and severity of airflow obstruction are needed to con-
firm the importance of our findings.
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